Ozette

“High-Resolution Immune Profiling”

Ozette’s immune profiling platform uses cutting edge A.I. to provide insights that help answer some of the most pressing questions, such as whether or not a therapy works for an individual patient or if we can determine a patient’s disease before they have physical manifestations. Answering these critical questions and understanding the complexity of the immune system in health and disease helps scientists and doctors to drive towards better patient outcomes.

Ozette has raised $6MM in seed funding from Madrona Venture Group and Vulcan Capital and $6MM in grant funding.

Learn More -->

Founders

Ali Ansary, PhD

Ali Ansary, PhD

Greg Finak, PhD

Greg Finak, PhD

Raphael Gottardo, PhD

Raphael Gottardo, PhD

If you’re ready to build an AI-first startup, then we want to talk to you

We invite talented engineers, researchers, and entrepreneurs to join our incubator on a rolling basis. If you have ever thought of starting an AI-first company, now is the time.

Apply Now